2021 IPPS PROPOSED RULE
CMS has published the Proposed 2021 Inpatient Prospective Payment Payment Rule. The deadline for comment is July 10, 2020. The Proposed Rule contains a number of notable items including:
- Proposed overall increase in IPPS payments of approximately 1.6%
- Proposed reduction of hospital payments for excess re-admissions
- ICD-10-CM update of nearly 500 new codes, 47 revised codes, and 58 deleted codes
- Proposed new technology add-on payments for antimicrobial products
- Proposed new MS-DRG for Chimeric Antigen Receptor (CAR) T-cell therapy
We recommend you read the
complete Proposed Rule to understand the changes and potential impact to your
facility.
The proposed rule can be accessed here: https://www.cms.gov/medicare/acute-inpatient-pps/fy-2021-ipps-proposed-rule-home-page
CMS Fact Sheet: https://www.cms.gov/newsroom/fact-sheets/fiscal-year-fy-2021-medicare-hospital-inpatient-prospective-payment-system-ipps-and-long-term-acute
COVID UPDATES
CMS has established a new
Level II HCPCS code C9803, for COVID-19 specimen collection under the
Outpatient Prospective Payment System. It is effective for services
provided on or after March 1, 2020. Any claims received on or after May
1, 2020 with the Coronavirus specimen collection codes G2023 or G2024 will be
returned.
CMS is also requiring, as part of the CARES Act, that providers of diagnostic
tests for COVID-19 post the cash price for a COVID-19 diagnostic test to their
website starting March 27, 2020 through the end of the public health crisis.
https://www.cms.gov/files/document/FFCRA-Part-42-FAQs.pdf
HBE is available to assist with updating your charge description master, training of your providers and staff, policy revisions, auditing and other compliance and revenue cycle needs you may have. We will continue to monitor these important developments.